The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)

CA115930

3023 (ClinVar)

Gene: ATM
Condition: hereditary breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 36ae7580-8da9-4ce9-9040-32e7eee1bb34
Approved on: 2022-03-09
Published on: 2022-07-11

HGVS expressions

NM_000051.3:c.7271T>G
NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)
NC_000011.10:g.108329202T>G
CM000673.2:g.108329202T>G
NC_000011.9:g.108199929T>G
CM000673.1:g.108199929T>G
NC_000011.8:g.107705139T>G
NG_009830.1:g.111371T>G
NG_054724.1:g.145631A>C
ENST00000278616.9:c.7271T>G
ENST00000525056.2:n.1690T>G
ENST00000525537.3:n.228T>G
ENST00000638786.2:n.108T>G
ENST00000682286.1:n.2028T>G
ENST00000682302.1:n.1689T>G
ENST00000683174.1:n.8755T>G
ENST00000683524.1:n.2495T>G
ENST00000684152.1:n.2985T>G
ENST00000684447.1:n.1734T>G
ENST00000527805.6:c.*2335T>G
ENST00000675595.1:c.*2406T>G
ENST00000675843.1:c.7271T>G
ENST00000278616.8:c.7271T>G
ENST00000452508.6:c.7271T>G
ENST00000524792.5:n.3486T>G
ENST00000525537.2:n.547T>G
ENST00000525729.5:c.641-20131A>C
ENST00000527389.2:n.296T>G
ENST00000533690.5:n.2675T>G
NM_001330368.1:c.641-20131A>C
NM_001351110.1:c.*38+6018A>C
NM_001351834.1:c.7271T>G
NM_001330368.2:c.641-20131A>C
NM_001351110.2:c.*38+6018A>C
NM_001351834.2:c.7271T>G
NM_000051.4:c.7271T>G
NM_000051.4(ATM):c.7271T>G (p.Val2424Gly)
More

Pathogenic

Met criteria codes 5
PS4 PP1 PP3 PM3_Very Strong PS3_Moderate
Not Met criteria codes 2
PM2 PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ATM Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Breast, Ovarian and Pancreatic Cancer VCEP
The ATM c.7271T>G (p.Val2424Gly) variant has a GnomAD (v2.1.1) allele frequency of 0.004124% (NFE) which is above the PM2 threshold of .001% but below the BS1 threshold of .05%. This variant is predicted deleterious by multiple protein in silico tools (PP3). This variant is non-functional in multiple different protein assays (PMIDs:19431188,18634022) (PS3_Moderate). The prevalence of the variant in affected individuals is significantly increased compared to the prevalence in controls in a case control study with lower CI ≥1.5 (PMIDs: 16958054, 21787400) (PS4). This variant has been observed in a homozygous and/or compound heterozygous state (presumed and/or confirmed) in multiple individuals with ataxia-telangiectasia (GeneDx, PMIDs: 9463314, 18575927, 27528516) (>8 points - PM3_Very strong). This variant co-segregated with ataxia-telangiectasia in multiple affected family members (PMID: 18575927) (PP1). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the HBOP Variant Curation Expert Panel.
Met criteria codes
PS4
Case Control Study with lower CI ≥1.5 (16958054, 21787400)
PP1
This variant co-segregated with ataxia telangiectasia in multiple affected family members (PMID: 18575927) (PP1).
PP3
This variant is predicted deleterious by multiple protein in silico tools (PP3)
PM3_Very Strong
This variant has been observed in a homozygous and/or compound heterozygous state (presumed and/or confirmed) in multiple individuals with Ataxia-Telangiectasia (GeneDx, PMIDs: 9463314, 18575927, 27528516) (18)
PS3_Moderate
Non-functional in multiple different protein assays (PMIDs:19431188,18634022)
Not Met criteria codes
PM2
This variant has a GnomAD (v2.1.1) allele frequency of 0.004124% (NFE) which is above the PM2 threshold of .001% but below the BS1 threshold of .05%.
PP4
Mother (HET) and 3 affected siblings (HOM) show normal size and levels of ATM protein (PMID 9463314)
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.